UBS Group’s Celgene Corporation Contingent Value Rights CELGZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-6,604
| Closed | -$4K | – | 7537 |
|
|
2019
Q3 | $4K | Buy |
6,604
+6,561
| +15,258% | +$3.97K | ﹤0.01% | 6632 |
|
|
2019
Q2 | $0 | Sell |
43
-9,543
| -100% | – | ﹤0.01% | 7438 |
|
|
2019
Q1 | $11K | Buy |
9,586
+9,543
| +22,193% | +$11K | ﹤0.01% | 5955 |
|
|
2018
Q4 | $0 | Sell |
43
-3,045
| -99% | – | ﹤0.01% | 7553 |
|
|
2018
Q3 | $5K | Buy |
3,088
+1,989
| +181% | +$3.22K | ﹤0.01% | 6615 |
|
|
2018
Q2 | $0 | Sell |
1,099
-8,087
| -88% | – | ﹤0.01% | 7478 |
|
|
2018
Q1 | $3K | Buy |
9,186
+1,036
| +13% | +$338 | ﹤0.01% | 6601 |
|
|
2017
Q4 | $8K | Buy |
8,150
+7,032
| +629% | +$6.9K | ﹤0.01% | 6226 |
|
|
2017
Q3 | $2K | Sell |
1,118
-7,338
| -87% | -$13.1K | ﹤0.01% | 6611 |
|
|
2017
Q2 | $10K | Buy |
8,456
+5,104
| +152% | +$6.04K | ﹤0.01% | 5872 |
|
|
2017
Q1 | $4K | Sell |
3,352
-17,792
| -84% | -$21.2K | ﹤0.01% | 6208 |
|
|
2016
Q4 | $21K | Buy |
21,144
+20,686
| +4,517% | +$20.5K | ﹤0.01% | 5558 |
|
|
2016
Q3 | $0 | Buy |
458
+415
| +965% | – | ﹤0.01% | 7205 |
|
|
2016
Q2 | $0 | Hold |
43
| – | – | ﹤0.01% | 7244 |
|
|
2016
Q1 | $0 | Hold |
43
| – | – | ﹤0.01% | 7258 |
|
|
2015
Q4 | $0 | Hold |
43
| – | – | ﹤0.01% | 7317 |
|
|
2015
Q3 | $0 | Sell |
43
-1,711
| -98% | – | ﹤0.01% | 7281 |
|
|
2015
Q2 | $4K | Sell |
1,754
-2,812
| -62% | -$6.41K | ﹤0.01% | 6415 |
|
|
2015
Q1 | $14K | Buy |
4,566
+4,560
| +76,000% | +$14K | ﹤0.01% | 5693 |
|
|
2014
Q4 | $0 | Buy |
+6
| New | – | ﹤0.01% | 6850 |
|